Survival statistics for prostate cancer

Last medical review:

Survival statistics for prostate cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person's chances of survival. In general, most men diagnosed with prostate cancer do not die from the disease itself and will die from other causes.

There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for prostate cancer and what they mean to you.

Net survival

Net survival represents the probability (chance) of surviving cancer in the absence of other causes of death. It is used to give an estimate of the percentage of people who will survive cancer.

In Canada, the 5-year net survival for prostate cancer is 91%. This means that, on average, about 91% of men diagnosed with prostate cancer will live for at least 5 years.

Survival by stage

Survival varies with each stage of prostate cancer. The grade of prostate cancer is also a strong predictor for survival.

Generally, the earlier prostate cancer is diagnosed and treated, the better the outcome. Because prostate cancer tends to grow slowly, it can often be successfully treated. Also, there are many treatments available for prostate cancer and it often responds well to treatment.

Advanced and recurrent prostate cancers and castration-resistant prostate cancer (prostate cancer that doesn't respond to hormone therapy or comes back after hormone therapy) can be hard to treat because they do not respond well to some treatments.

In Canada, survival by stage for prostate cancer is reported as 5-year net survival.


5-year net survival







4 41%
stage not known 79%

Questions about survival

Talk to your doctor about your prognosis. A prognosis depends on many factors, including:

  • your health history
  • the type of cancer
  • the stage
  • certain characteristics of the cancer
  • the treatments chosen
  • how the cancer responds to treatment

Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.

Expert review and references

  • Peter Chung, MBChB, FRCPC
  • Krista Noonan, MD, FRCPC
  • American Society of Clinical Oncology. Prostate Cancer. 2020:
  • PDQ® Adult Treatment Editorial Board. Prostate Cancer Treatment (PDQ®)–Health Professional Version. Bethesda, MD: National Cancer Institute; 2020:
  • Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2021. Canadian Cancer Society; 2021.
  • Ellison LF, Saint-Jacques N. Five-year cancer survival by stage at diagnosis in Canada. Health Reports. Ottawa, ON : Statistics Canada; 2023: 34(1):3–15.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on, nor do we endorse any service, product, treatment or therapy.

1-888-939-3333 | | © 2024 Canadian Cancer Society